Cipher Pharmaceuticals, Inc. (CPHR)
OTOTC · Common · CUSIP 17253X105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CPHR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
17253X105
Market Cap
Small Cap · $363 Million
Business: Cipher Pharmaceuticals, Inc. is a growing specialty pharmaceutical company with three commercial products and a fourth in development, which are improved formulations of successful marketed drugs. Cipher acquires products that fulfill high unmet medical needs, manage the required clinical development and regulatory approval process, and market those products either directly or through partners. The Company's core capabilities include clinical and regulatory affairs, product licensing, supply chain management, and marketing and sales.

Company Contact

CEO
Shawn O’Brien
CFO
Norman Evans
Headquarters
5650 Tomken Road, Unit 16, Mississauga, Ontario L4W 4P1
Phone
905-602-5840
Fax
905-602-0628
Investor Relations
Michael Moore, TMX Equicom · 858-886-7813 · MMoore@tmxequicom.com
General Email
info@cipherpharma.com
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »